Advocacy intelligence hub — real-time data for patient organizations
Alexion Pharmaceuticals, Inc. — NA
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs1
KANUMA
Alexion Pharmaceuticals, Inc.
KANUMA
(SEBELIPASE ALFA)Orphan drugstandardAlexion Pharmaceuticals, Inc.
Paul Orchard, MD, MD
University of Minnesota Medical Center
📍 MINNEAPOLIS, MN
Tippi C MacKenzie, MD
University of California, San Francisco
📍 San Francisco, California
Mitchell S Cairo, MD, MD
New York Medical College
📍 HAWTHORNE, NY
Florian Abel, MD
Alexion Pharmaceuticals, Inc.
Gregory A Grabowski, MD
Children's Hospital Medical Center, Cincinnati
Tippi MacKenzie, MD
University of California, San Francisco
📍 San Francisco, California